|
New York
City—The New
York Stem
Cell
Foundation (NYSCF)
welcomed its
2010
NYSCF-Druckenmiller
Fellows at a
reception at
25 Columbus
Circle. The
event was
hosted by
NYSCF Chief
Executive
Officer
Susan L.
Solomon
and Dr.
Roy
Geronemus,
Chairman of
its board
and NYSCF’s
board of
directors.
Attendees at
the event
included
Stanley and
Fiona
Druckenmiller,
Trustees of
the
Druckenmiller
Foundation;
the artist
Christo;
Dr. Bill
Haseltine,
Chairman and
CEO of
Haseltine
Associates;
Dr. John
Hood,
President
and CEO, and
Phoebe
Boyer,
Executive
Director, of
Robertson
Foundation;
Tom
Jackson,
Founder of
the Pamela
B. and
Thomas C.
Jackson
Charitable
Fund;
Stuart Suna,
Co-owner of
Silvercup
Studios;
Maria Gotsch,
Co-CEO and
Co-President
of the New
York City
Investment
Fund;
Frank and
Victoria
Wyman;
Barbara
Gollust,
former
Director of
Arbitrage at
Wertheim
Schroeder;
John
Dickey,
Co-Chair of
Gibson, Dunn
& Crutcher’s
National
Securities
Litigation
Practice;
Dr. Peter
Schlossberg
of Columbia
University;
Keith
Jewell,
Co-founder
of
Papamarkou
Asset
Management;
Lisa
Jewell,
of the Lisa
Papamarkou
Jewell
Foundation
of Animal
Welfare;
Liz Robbins,
President of
Liz Robbins
Associates;
Pam
Laudenslager,
President of
Hemisphere 2
Entertainment;
actress/producer
Fay Morley;
novelist/
playwright/educator
Penny
Jackson;
and
Ann Davis,
Director of
Legal
Services for
the National
Multiple
Sclerosis
Society-NY
Chapter.
Attendees
from NYSCF,
included
CFO Jeff
Wallerstein;
Dr. Olivia
Flatto,
Director of
External
Affairs; and
board
members
Paul
Goldberger,
Architecture
Critic for
The New
Yorker; |
Carol
Einiger,
President
Post Rock
Advisors,
LLC; Dr.
Karen Burke;
Alan
Cohen,
Executive
Vice
President
and Global
Head of
Compliance
at Goldman
Sachs;
Marilyn
Breslow,
former
President
and Senior
Portfolio
Manager of
W.P. Stewart
& Co., Inc.
The New York
Stem Cell
Foundation
Fellows are
an elite
group of
postdoctoral
scientists
leading
their
generation
in the field
of stem cell
research.
The new
NYSCF-Druckenmiller
Fellows for
2010 are
Dr. Marco
Seandel,
Weill
Cornell
Medical
College;
Dr. Keiichi
Inoue,
Columbia
University;
Dr.
Dung-Fang
Lee,
Mount Sinai
School of
Medicine;
Dr. Noi
Talchi,
Columbia
University;
Dr. Maya
Tevlin,
The
Rockefeller
University;
Dr.
Dieter Egli,
NYSCF;
Dr.
Christopher
A. Fasano,
New York
Neural Stem
Cell
Institute;
Dr.
Valentina
Fossati,
Mount Sinai
School of
Medicine;
Dr. Daylon
James,
Weill
Cornell
Medical
College;
Dr. Ian
Martin,
Johns
Hopkins
University;
Dr. Elisa
Cimetta,
Columbia
University;
Dr. Jae-won
Shim,
Memorial
Sloan-Kettering
Cancer
Center; and
Dr.
Sriram Bandi,
Albert
Einstein
College of
Medicine.
About The
New York
Stem Cell
Foundation:
Founded in
2005, The
New York
Stem Cell
Foundation (NYSCF)
is dedicated
to
accelerating
cures for
the major
diseases of
our time
through stem
cell
research.
NYSCF opened
the first
privately
funded stem
cell
laboratory
in New York
City, where
NYSCF
researchers
and
collaborating
scientists
conduct
advanced
stem cell
research
free of
federal
restrictions.
The
organization
supports
scientists
engaged in
stem cell
research
through the
NYSCF
Fellowship
Program, its
annual
translational
stem cell
research
conference
and other
symposia.
NYSCF runs
collaborative;
state-of-the-art
research
facilities
directly
focused on
curing
disease and
educates the
public about
the
importance
and
potential
benefits of
stem cell
research.
For more
information,
visit www.nyscf.org.
|